Naltrexone for Overdose Prevention | MicrobiomeTrials← Back to trialsNCT06633900
Naltrexone for Overdose Prevention
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2025-04-10Est. Completion: 2027-04-15
Enrollment target: 100 participants Locations- Center on Substance Use and Health, San Francisco, California, United States
Other microbiome trials you might be interested in
Drug OverdoseDrug Overdose Accidental
BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who…
San Francisco, United StatesEst. completion Jan 15, 2030
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
The purpose of this study is to characterize participants with Crohn's Disease (CD) and Ulcerative Colitis (UC) treated …
Berlin, GermanyEst. completion Jan 15, 2029